Login / Signup

An alternative way - tyrosine kinase inhibitor (TKI) de-escalation - to discontinue TKIs in order to achieve treatment-free remission.

Ahmad KunbazAhmet Emre Eskazan
Published in: Expert review of hematology (2019)
Keyphrases
  • tyrosine kinase
  • open label
  • randomized controlled trial
  • advanced non small cell lung cancer
  • disease activity
  • systemic lupus erythematosus
  • replacement therapy